
Andrew Owen
Molecular and Clinical Pharmacology at University of Liverpool
Andrew Owen, PhD FSB is a Professor in the Department of Molecular and Clinical Pharmacology at the University of Liverpool, UK. He is also affiliated to the MRC Centre for Drug Safety Science and the Wolfson Centre for Personalised Medicine.
Professor Owen has contributed to over 100 original research and review publications, book chapters and patent applications. In recent years, research funding has been secured from the Medical Research Council, Engineering and Physical Sciences Research Council, US National Institutes of Health and the British Society for Antimicrobial Chemotherapy.
He is Chair of the British Society for Nanomedicine (www.BritishSocietyNanomedicine.org), a fellow of the Society of Biology and a member of the Nanomed Focus Group Steering Committee, British Pharmacological Society and Critical Path to TB Drug Regimens.
He is also a member of the editorial board for Nanomedicine: nanotechnology, biology and medicine.
Why you can trust Good Good Good:
• Good Good Good is fully independent and funded by readers — with no billionaire owners or investors.
• All of our articles are researched and written by professional journalists.
• Our newsroom has a zero AI articles policy. We don’t use AI in our news stories or photos. Humans write every word.
• Good Good Good is committed to the highest newsroom standards and ethics.
→ Read Good Good Good’s Editorial Standards

